LB Pharmaceuticals Inc. (LBRX) Maintains Buy Rating as Analyst Highlights LB-102 Potential
TheFly reported on May 28 that Clear Street maintained a Buy rating and a $45 price target for LBRX.
Lb Pharmaceuticals Inc (LBRX)
Market is closed
Sector: Healthcare
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.00 | 666,666 | $9,999,990.00 | 666,666 | 2025-09-12 | Filing | |
| $15.00 | 2,000,000 | $30,000,000.00 | 2,686,138 | 2025-09-12 | Filing | |
| $15.00 | 1,000,000 | $15,000,000.00 | 1,411,681 | 2025-09-12 | Filing | |
| $15.00 | 1,000,000 | $15,000,000.00 | 1,411,681 | 2025-09-12 | Filing | |
| $15.00 | 767 | $11,505.00 | 2,029 | 2025-09-12 | Filing |
News See All
8 Best Up and Coming Pharmaceutical Stocks to Buy Now
Investors looking for substantial potential without making a sizable initial investment continue to be drawn to inexpensive stocks.
Hedge Fund Resource Center